Oppenheimer analyst Leah Rush Cann raised her price target on Celgene (NASDAQ: CELG) to $148.00 (from $141.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE